10 principais lunsumio.com concorrentes

foresight-dx.com

Expands Natera’s lead in solid tumor MRD, acquiring ultrasensitive phased variant technology with LOD95 of 0.3 parts per million (ppm) and detection below 0 ...

breyanzi.com

Breyanzi® (lisocabtagene maraleucel) CAR T cell therapy treatment is used to treat adult patients with relapsed/refractory large B-cell lymphoma (LBCL). Please see full Prescribing Information, including Boxed WARNINGS and Medication Guide.

yescartahcp.com

Learn about how YESCARTA® (axicabtagene ciloleucel) works. See full Prescribing Information, including BOXED WARNING.

tazverik.com

Recommended dosing for TAZVERIK® (tazemetostat), an oral, twice-daily tablet for patients with advanced epithelioid sarcoma. Avoid coadministration of strong or moderate CYP3A inhibitors with TAZVERIK. If coadministration of strong or moderate CYP3A inhibitors cannot be avoided, reduce TAZVERIK dose. Avoid coadministration of moderate or strong CYP3A inducers with TAZVERIK, which may decrease the efficacy of TAZVERIK. Coadministration of TAZVERIK with CYP3A substrates, including hormonal contraceptives, can result in decreased concentrations and reduced efficacy of CYP3A substrates. See Important Safety Information and full Prescribing Information, including Medication Guide.

polivy.com

Find a list of questions to start a conversation with your doctor about POLIVY® (polatuzumab vedotin-piiq) plus R-CHP and DLBCL. See full safety information.

gazyva.com

Learn about lupus nephritis, its causes, symptoms, and how GAZYVA® (obinutuzumab) may help. Explore resources for patients and caregivers. See Important Safety Information including Serious Side Effects for more information.

herceptin.com

Find information about Herceptin® (trastuzumab), a treatment for HER2+ early and metastatic breast cancer and stomach cancer/GEJ. See full safety & Boxed Warnings for more information.

itovebi.com

Learn about the financial assistance options for people taking Itovebi® (inavolisib), including for those who don't have insurance. See full safety for more information.

jelmyto.com

JELMYTO is the first and only FDA-approved treatment of low-grade upper tract urothelial cancer (LG-UTUC) in adult patients

kisqali-hcp.com

learn about kisqali, a cdk4/6 inhibitor used to treat hr+/her2- metastatic breast cancer and early breast cancer. see full prescribing & safety info